Ferring would like to use cookies to better understand your use of this website and improve your experience while navigating it. Please accept our use of cookies in accordance with our privacy policy

Accept / Decline

Stories

Why Inflammatory Bowel Disease continues to grow?

Ferring raises awareness about IBD

Today, over 5 million people worldwide suffer from Inflammatory Bowel Disease (IBD).1 What is concerning is that this number continues to grow, with 1 in 4 new diagnoses being made in children.2 Many researchers speculate on the reason for this alarming fact, with discussions around both genetic and environmental factors such as the increased adoption of a Western diet, high in refined carbohydrates, sugar and fat.3 The exact cause of IBD, which includes both Ulcerative Colitis and Crohn’s disease, still remains unknown.4

Another potential theory concerns the imbalance of the intestinal microbiome, the community of tiny organisms that naturally live in our guts.3,5 Our body needs to maintain a certain balance of these bacteria to fight off infection and disease.3,5 Certain factors, such as smoking or diet, have the possibility of negatively affecting the microbiome, leaving certain susceptible individuals at risk of gastrointestinal diseases, such as IBD.3,5

In light of these theories, Ferring recognises the need to raise awareness of the disease with the aim of offering more hope to IBD patients and help them live better lives On the occasion of World IBD Day 2018, Ferring seeks to draw more attention to patients who are suffering of IBD with the release of pertinent information about the disease. As a leader in gastroenterology, Ferring continues to explore new options, through investing in research and development, for the management of gastrointestinal conditions, including IBD.

Discover more on IBD - key facts and figures about IBD.

Whether you are a patient, a caregiver or a doctor, visit our Guts4Life website to help you learn more about IBD and how to control it.

References:

  1. Hammer T et al., J Crohn’s Colitis 2016;10(8):934–942.
  2. Trivedi I and Keefer L. Gastroenterol Res Pract 2015;2015:260807.
  3. DeGruttola AK et al. Inflamm Bowel Dis 2016;22(5): 1137–1150.
  4. Derwa Y et al. Aliment Pharmacol Ther. 2017;46:389–400.
  5. Halfvarson J et al. Nat Microbiol 2017;2:17004.

Headquarters

FERRING INTERNATIONAL CENTER S.A.
CH. DE LA VERGOGNAUSAZ 50
1162 SAINT-PREX
SWITZERLAND

TEL:  +41 58 301 00 00
FAX: +41 58 301 00 10

CONTACT

Global Locator